Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ashvattha Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Ashvattha Therapeutics

Ashvattha Therapeutics

Series B

Ashvattha Therapeutics: Innovating biopharmaceuticals for human and veterinary use since 2016.

HQ
Redwood City, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded in 2016, Ashvattha Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics for both human and veterinary use. The company’s core mission is to advance disease cell-targeted precision medicine through a new class of clinical-stage nanomedicine therapeutics. Their product pipeline includes innovative treatments such as D-4517.2, OP-801, and OP-101, which are designed to address unmet medical needs in various diseases.

Ashvattha Therapeutics has garnered attention from notable figures in the scientific community and has secured investments from leading biotech investors. The company’s senior management team and board of directors comprise experienced professionals with significant expertise in pharmaceuticals and biotechnology. Key achievements include advancing their nanomedicine candidates into clinical trials, demonstrating their potential to transform therapeutic approaches. Overall, Ashvattha Therapeutics is making a significant impact on the biopharmaceutical landscape with its cutting-edge technologies and commitment to precision medicine.

Ashvattha Therapeutics - Similar Companies

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

Avalo Therapeutics logo

Avalo Therapeutics

avalotx.com

Asha Therapeutics logo

Asha Therapeutics

Athos Therapeutics logo

Athos Therapeutics

athostx.com

Attovia Therapeutics logo

Attovia Therapeutics

Avstera Therapeutics logo

Avstera Therapeutics

avstera.com

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

Advanced NanoTherapies logo

Advanced NanoTherapies

NanoPharmaceuticals logo

NanoPharmaceuticals

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

Atavistik Bio logo

Atavistik Bio

atavistikbio.com

Aztherapies logo

Aztherapies

Alphina Therapeutics logo

Alphina Therapeutics

Anthos Therapeutics logo

Anthos Therapeutics

Theravance Biopharma logo

Theravance Biopharma

theravance.com

Ashvattha Therapeutics - Quick Facts

Who are Ashvattha Therapeutics' competitors?

Companies similar to Ashvattha Therapeutics include Astria Therapeutics, Avalo Therapeutics, Asha Therapeutics and Athos Therapeutics.

When was Ashvattha Therapeutics founded?

Ashvattha Therapeutics was founded in 2015.

Where is Ashvattha Therapeutics' headquarters located?

Ashvattha Therapeutics' headquarters is located in Redwood City, CA, US.

How much has Ashvattha Therapeutics raised to-date?

As of Apr 24, 2023, Ashvattha Therapeutics has raised a total of $98M (USD).

How many employees does Ashvattha Therapeutics have?

Ashvattha Therapeutics has 42 employees as of Feb 5, 2024.

Ashvattha Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Nanomedicine
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biopharmaceuticals
  • Therapeutics
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified